- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Castrate-Resistant Prostate Cancer (mCRPC) in United Kingdom
Total 706 results
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate CancerUnited States
-
Movember FoundationKing's College London; Centre hospitalier de l'Université de Montréal (CHUM); University of California, San Francisco and other collaboratorsActive, not recruitingINTense ExeRcise for surviVAL Among Men With Metastatic Prostate Cancer (INTERVAL - GAP4) (INTERVAL)Metastatic Prostate CancerUnited States, Australia, Netherlands, Canada, United Kingdom, Germany, Ireland
-
National Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Lymph NodesUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Mayo ClinicCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
University of UtahTerminatedStage IV Prostate Cancer | Metastatic Prostatic Adenocarcinoma | Castration-Sensitive Prostate Carcinoma | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, IncNot yet recruiting
-
Columbia UniversityActive, not recruitingMetastatic Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedMetastatic Prostate CancerUnited States
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
Roswell Park Cancer InstituteRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...Approved for marketingProstatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Carcinoma Metastatic in the BoneUnited States
-
Dana MathewsCompletedProstate Cancer | Prostate Cancer MetastaticUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
Burzynski Research InstituteTerminatedMetastatic Prostate CancerUnited States
-
Regeneron PharmaceuticalsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Dana-Farber Cancer InstitutePfizer; Astellas Pharma IncCompletedCastration-resistant Prostate CancerUnited States
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterExelixisTerminatedProstate Cancer MetastaticUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)Enrolling by invitationProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Prostate Neoplasms | Prostatic CancerUnited States
-
Imperial College LondonWellcome TrustRecruitingProstate Cancer | Metastatic Prostate CancerUnited Kingdom
-
Royal Marsden NHS Foundation TrustJanssen, LPRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)United Kingdom
-
Sharp HealthCareWithdrawnMetastatic Prostate CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterWake Forest University Health SciencesCompletedCastration-resistant Prostate Cancer | Androgen Deprivation TherapyUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
BIND TherapeuticsCompleted
-
BayerCompleted
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
AstraZenecaCompletedAdvanced Solid Malignancies | Non-Small Cell Lung Cancer (NSCLC) | Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) | Colorectal Carcinoma (CRC)United States
-
University of HawaiiGenentech, Inc.; DendreonCompletedProstate Cancer MetastaticUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Duke UniversityExelixisTerminatedProstate Cancer | Prostate Cancer Adenocarcinoma | Non-MetastaticUnited States
-
Accelerated Community Oncology Research NetworkBayerTerminatedMetastatic Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingProstatic Neoplasms | Prostate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | ProstateUnited States
-
National Cancer Institute (NCI)Enrolling by invitationProstate Cancer | Metastatic Prostate Cancer | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticUnited Kingdom, Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain
-
Emmanuel Antonarakis, MDMillennium Pharmaceuticals, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate CancerUnited States
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States